AD-EVs showed reduced levels of proteins involved in neural development and synaptic functioning, and upregulation of proteins with roles in Aβ aggregation, tau phosphorylation, inflammation, and protein quality control. The gene discussed is MAPT; the disease is Alzheimer disease.